Glycopyrrolate by is a Prescription medication manufactured, distributed, or labeled by Zydus Lifesciences Limited. Drug facts, warnings, and ingredients follow.
NDC: 70771-1616-1
Glycopyrrolate Injection, USP
0.2 mg/mL
NOT FOR USE IN NEWBORNS
CONTAINS BENZYL ALCOHOL
FOR INTRAMUSCULAR OR
INTRAVENOUS ADMINISTRATION
1 mL Single-Dose Vial
Rx only
NDC: 70771-1616-7
Glycopyrrolate Injection, USP
0.2 mg/mL
NOT FOR USE IN NEWBORNS
CONTAINS BENZYL ALCOHOL
FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION
25 x 1 mL Single-Dose Vials
Rx only
NDC: 70771-1617-1
Glycopyrrolate Injection, USP
0.4 mg/2 mL
(0.2 mg/mL)
NOT FOR USE IN NEWBORNS
CONTAINS BENZYL ALCOHOL
FOR INTRAMUSCULAR OR
INTRAVENOUS ADMINISTRATION
2 mL Single-Dose Vial
Rx only
NDC: 70771-1617-7
Glycopyrrolate Injection, USP
0.4 mg/2 mL
(0.2 mg/mL)
NOT FOR USE IN NEWBORNS
CONTAINS BENZYL ALCOHOL
FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION
25 x 2 mL Single-Dose Vials
Rx only
NDC: 70771-1618-1
Glycopyrrolate Injection, USP
1 mg/5 mL
(0.2 mg/mL)
NOT FOR USE IN NEWBORNS
CONTAINS BENZYL ALCOHOL
FOR INTRAMUSCULAR OR
INTRAVENOUS ADMINISTRATION
5 mL Multiple-Dose Vial
Rx only
NDC: 70771-1618-7
Glycopyrrolate Injection, USP
1 mg/5 mL
(0.2 mg/mL)
NOT FOR USE IN NEWBORNS
CONTAINS BENZYL ALCOHOL
FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION
25 x 5 mL Multiple-Dose Vials
Rx only
NDC: 70771-1619-1
Glycopyrrolate Injection, USP
4 mg/20 mL
(0.2 mg/mL)
NOT FOR USE IN NEWBORNS
CONTAINS BENZYL ALCOHOL
FOR INTRAMUSCULAR OR
INTRAVENOUS ADMINISTRATION
20 mL Multiple-Dose Vial
Rx only
NDC: 70771-1619-6
Glycopyrrolate Injection, USP
4 mg/20 mL
(0.2 mg/mL)
NOT FOR USE IN NEWBORNS
CONTAINS BENZYL ALCOHOL
FOR INTRAMUSCULAR OR INTRAVENOUS ADMINISTRATION
10 x 20 mL Multiple-Dose Vials
Rx only
GLYCOPYRROLATE
glycopyrrolate injection |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
GLYCOPYRROLATE
glycopyrrolate injection |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
GLYCOPYRROLATE
glycopyrrolate injection |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
GLYCOPYRROLATE
glycopyrrolate injection |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Zydus Lifesciences Limited (918596198) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Zydus Lifesciences Limited | 873671928 | MANUFACTURE(70771-1616, 70771-1617, 70771-1618, 70771-1619) , ANALYSIS(70771-1616, 70771-1617, 70771-1618, 70771-1619) |